Preclinical Research
Services
Feasibility, protocol consultation, and translational support that bridges bench science to first-in-human readiness.
Read more
From first feasibility call to final close-out visit, every engagement is backed by physician oversight, in-house bioanalytical science, and AI-assisted analysis.
Core capabilities
Five integrated capabilities that sponsors can engage independently or as a full-service package.
Engagement Models
Patient recruitment, screening, enrollment, study visits, safety monitoring, data entry, regulatory maintenance, sample collection, and bioanalytical services.
Ideal for: Phase I-IV drug trials, device trials, vaccine studies
Start Trial Enquiry
How we work
A typical timeline runs 4-6 weeks from contract execution to first patient screened; expedited pathways are available for urgent studies.
Step 01 of 05
Sponsors contact Mount Clinical Research directly or through CRO partners. Initial discussions cover therapeutic area, protocol synopsis, enrollment targets, and timeline.
Performance commitments
Commitment to meet or exceed agreed-upon enrollment projections with proactive recruitment strategies.
Target of less than 2% query rate, with real-time data entry within 24 hours of each visit.
SAE notification within 24 hours; complete narratives delivered within 5 business days.
Weekly enrollment updates, monthly study status reports, and immediate escalation of issues.
Partner with us
Whether you need a full-service site, in-house bioanalytical support, or a FlowAutoGate™ pilot, our team can typically turn around a feasibility response within 5 business days.
